ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Eribulin Advanz Pharma 0.44 mg/ml, Injektionslösung - 
69924001 Advanz Pharma Specialty Medicine Switzerland GmbH
Eribulin Advanz Pharma 0.44 mg/ml, Injektionslösung26.06.2025
  26.06.2025
Eribulin (L01XX41) 
WHO-DDD25.06.2030
 
07.16.10. 
A  
No 
  
PR  
k.A.PR
  
7680699240012Synthetika
  
Composition
eribulinum 0.88 mg ut eribulini mesilas 1 mg, ethanolum anhydricum 0.1 ml, natrii hydroxidum q.s. ad pH, acidum hydrochloridum q.s. ad pH, aqua ad iniectabile q.s. ad solutionem pro 2 ml.
Packungsbestandteile
Injection solution
 
 
Active AgentDose
Eribulinum0.88 mg
 
Inactive agentsDose
Ethanol Anhydrate0.1 ml
Sodium Hydroxide 
Source
Data was imported : 11.07.2025 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home